Structural rationalization of IPMK inhibitor potency.
Abstract
Inositol polyphosphate multikinase (IPMK) is a kinase linked to several cancers, recent development of a large panel of ATP-competitive inhibitors has reinvigorated enthusiasm for targeting IPMK. However, the structural basis for how these inhibitors achieve high potency is unknown. Here, we report 14 novel co-crystal structures (1.7[A] - 2.0[A] resolution) of human IPMK kinase domain with these inhibitors. We also apply a radiolabeled assay and isothermal titration calorimetry that permit high-confidence IC50 and KD value determinations. The structures reveal a pocket in the ATP-binding site engaged by the most potent inhibitors. Two ordered waters also participate in hydrogen-bonding networks associated with the most potent inhibitors. In addition to providing the molecular basis for observed increases in potency and selectivity, the data presented here provide a toolbelt of 14 novel inhibitor-bound structures of human IPMK that can serve as a reference for all future IPMK structure-based inhibitor development efforts.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 3
- FWCI
- 0.72
- Field percentile
- top 33%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Crystallographic and kinetic analyses of human IPMK reveal disordered domains modulate ATP binding and kinase activity.
C. D. Seacrist, R. D. Blind·bioRxiv·Oct 3, 2018
- Crystal structure of activated MAPKAPK2 kinase reveals a C-lobe allosteric pocket for furan-2-carboxamide inhibitors
Edward Beaumont, Stéphanie Duclos, … john Barker·bioRxiv·Oct 7, 2026
- Structural Analysis of Inhibitor Binding to CAMKK1 Identifies Features Necessary for Design of Specific Inhibitors
A. d. S. Santiago, R. M. Counago, … J. Elkins·bioRxiv·Mar 31, 2018
- An unconventional gatekeeper mutation sensitizes inositol hexakisphosphate kinases to an allosteric inhibitor
T. Aguirre, G. L. Dornan, … D. Fiedler·bioRxiv·Apr 26, 2023
- Design, synthesis and cellular characterization of a new class of IPMK kinase inhibitors
Yubai Zhou, Pratima Chapagain, … Xiaodong Wang·Journal of Medicinal ChemistryPeer-reviewed·Jul 25, 2025
- Catalytic domain plasticity of MKK7 reveals structural mechanisms of allosteric activation and new targeting opportunities
M. Schroeder, L. Tan, … A. Chaikuad·bioRxiv·Jun 11, 2020